All news

OrbiMed takes 12.3% Aspen Neuroscience stake via IPO shares

Alpha Vantage · TradingView · · AI-summarised by FinFlash

OrbiMed Advisors LLC has disclosed a 12.3% beneficial ownership stake in Aspen Neuroscience, Inc. The investment firm acquired the shares through preferred-stock conversions related to Aspen's IPO and a direct purchase of 1 million IPO shares at

Read original source

ASPE company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.